Show simple item record

dc.contributor.authorOwen, C
dc.contributor.authorConstantinidou, A
dc.contributor.authorMiah, AB
dc.contributor.authorThway, K
dc.contributor.authorFisher, C
dc.contributor.authorBenson, C
dc.contributor.authorZaidi, S
dc.contributor.authorMessiou, C
dc.contributor.authorVAN DER Graaf, WTA
dc.contributor.authorJones, RL
dc.date.accessioned2018-11-14T12:11:41Z
dc.date.issued2018-09
dc.identifier.citationAnticancer research, 2018, 38 (9), pp. 5275 - 5282
dc.identifier.issn0250-7005
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/2935
dc.identifier.eissn1791-7530
dc.identifier.doi10.21873/anticanres.12853
dc.description.abstractBackground/aim Synovial sarcoma is a soft tissue sarcoma that tends to affect young adults. There are few reports on primary synovial sarcoma of the thyroid and the aim of this study was to document the clinical and pathological features of synovial sarcoma occurring at this site.Case presentation A retrospective review of a prospectively maintained database was performed to identify patients with synovial sarcoma of the thyroid treated at the Royal Marsden Hospital between 2000 and 2017. Five patients were identified that underwent initial surgical management of localized disease. The mean age at presentation was 38 years, and male to female ratio was 4:1. In 3 out of 5 cases, the diagnosis of synovial sarcoma was made on the post-operative excision specimen. Two of these patients were treated at our institution on the development of metastatic disease. We conducted a literature review and identified 12 previously reported cases of synovial sarcoma of the thyroid.Conclusion Synovial sarcoma of the thyroid is rare and can be challenging to diagnose. The clinical presentation is typically indistinguishable from that of thyroid cancer and most cases are diagnosed post-operatively on an excision specimen. The clinical and pathological features are similar to synovial sarcoma arising at other sites. In our experience, the rarity of the diagnosis can lead to difficulty in establishing the correct diagnosis and determining the appropriate treatment pathway. It is important that physicians are aware of this diagnosis to facilitate prompt referral to a specialist centre, for specialist follow-up and treatment which is different to the thyroid cancer pathway.
dc.formatPrint
dc.format.extent5275 - 5282
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://www.rioxx.net/licenses/all-rights-reserved
dc.subjectHumans
dc.subjectSarcoma, Synovial
dc.subjectThyroid Neoplasms
dc.subjectNeoplasm Metastasis
dc.subjectDiagnosis, Differential
dc.subjectRetrospective Studies
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAged
dc.subjectMiddle Aged
dc.subjectDisease Management
dc.subjectFemale
dc.subjectMale
dc.titleSynovial Sarcoma of the Thyroid Gland, Diagnostic Pitfalls and Clinical Management.
dc.typeJournal Article
dcterms.dateAccepted2018-08-21
rioxxterms.versionofrecord10.21873/anticanres.12853
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2018-09
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfAnticancer research
pubs.issue9
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials (R Jones)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials (R Jones)/Sarcoma Clinical Trials (R Jones) (hon.)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials (R Jones)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials (R Jones)/Sarcoma Clinical Trials (R Jones) (hon.)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume38en_US
pubs.embargo.termsNot known
icr.researchteamSarcoma Clinical Trials (R Jones)en_US
icr.researchteamTargeted Therapyen_US
dc.contributor.icrauthorFisher, Cyril
dc.contributor.icrauthorZaidi, Shane Haider
dc.contributor.icrauthorMessiou, Christina
dc.contributor.icrauthorJones, Robin


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record